Stocktoria

Medline Inc. MDLN

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-12-17 · LEI

Medline Inc. (MDLN) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $28.4B at a 4.1% net margin.

Chart by TradingView
64/100
Stocktoria Quality Score · grade B
6/9
Piotroski F — financial health
2.84
Altman Z″ — distress risk · safe
Dividend yield · no dividend
-2.44
Beneish M-score — earnings quality · low
$35.50 as of 2026-08-01
$35.50$47.5152-wk

Beneish M-score: -2.44 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$51.1B
P / E44.1×
Net margin 5y avg4.1%
Employees45,000

Analyst price target

$45.27 +27.5% vs last
consensus: buy · 26 analysts
target range $34.00 – $62.00 · median $45.00
7 strong buy · 16 buy · 4 hold
Recent analyst actions
DateFirmRating
2026-08-12JP MorganOverweight (main)
2026-08-11Tigress FinancialBuy (main)
2026-08-11Wells FargoEqual-Weight (main)
2026-08-10TD CowenBuy (main)
2026-08-06RBC CapitalOutperform (main)
2026-08-06Truist SecuritiesBuy (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Forward estimates · earnings calendar →

Forward EPS est.$1.58
Forward P / E22.4×

Consensus analyst estimates and scheduled dates — forward-looking, may change.

Revenue trend · last 2y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 78%
Net marginstronger than 65%
Return on equitystronger than 67%
Revenue growthstronger than 68%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 6/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.213
Retained earnings / assets0.0
EBIT / assets0.057
Equity / liabilities1.005

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
MDLNMedline Inc.6/92.8444.1+11.5%
SYKSTRYKER CORP4/93.9639.3+11.2%
MMM3M CO5/95.4626.3+1.5%
BDXBECTON DICKINSON & CO6/92.2925.6+8.2%
BSXBOSTON SCIENTIFIC CORP4/92.81+19.9%
BAXBAXTER INTERNATIONAL INC5/93.86+5.7%
SOLVSolventum Corp6/92.348.9+0.9%

All Manufacturing companies →

About Medline Inc.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

FAQ

Is MDLN financially healthy?

Medline Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does MDLN pay a dividend?

No, Medline Inc. does not currently pay a dividend.

How profitable is MDLN?

In FY2025, Medline Inc. had a net margin of 4.1% and a return on equity of 6.0%.

What is MDLN's P/E ratio?

Medline Inc.'s trailing price-to-earnings (P/E) ratio is about 44.1×, based on its latest annual earnings.

What is the analyst price target for MDLN?

The average Wall-Street price target for Medline Inc. is $45.27, about 27.5% above the recent price, from 26 analysts (consensus: buy).

Is MDLN a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Medline Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 44.1×. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.